QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20 会议论文 作者:  Du Bois, Andreas;  Vergote, Ignace;  Ferron, Gwenael;  Reuss, Alexander;  Meier, Werner 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20 作者:  Scambia, Giovanni;  Johnson, Toby;  Floquet, Anne;  Heitz, Florian;  Park, Sang-Yoon 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Randomized, double-blind, phase III trial of pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (AEOC): Results of an international Intergroup trial (AGO-OVAR16). 会议论文 作者:  Du Bois, Andreas;  Floquet, Anne;  Kim, Jae Weon;  Rau, Joern;  Maria Del Campo, Jose 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 Randomized, double-blind, phase III trial of pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer (AOC): Results of an international intergroup trial (AGO-OVAR16). 会议论文 作者:  Du Bois, Andreas;  Floquet, Anne;  Kim, Jae Weon;  Rau, Joern;  Del Campo, Jose Maria 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19